Tony Petrella

Summary

Country: France

Publications

  1. ncbi 'Agranular CD4+ CD56+ hematodermic neoplasm' (blastic NK-cell lymphoma) originates from a population of CD56+ precursor cells related to plasmacytoid monocytes
    Tony Petrella
    Centre de Pathologie of Dijon and the Department of Pathology, Dijon University Hospital, France
    Am J Surg Pathol 26:852-62. 2002
  2. ncbi Tumoral aspects of plasmacytoid dendritic cells: what do we know in 2009?
    Tony Petrella
    Centre de Pathologie and Department of Pathology, University Hospital, Dijon, France
    Autoimmunity 43:210-4. 2010
  3. ncbi Indolent CD8-positive lymphoid proliferation of the ear: a distinct primary cutaneous T-cell lymphoma?
    Tony Petrella
    Department of Pathology of Dijon s University Hospital and the Centre de Pathologie of Dijon, 2100 Dijon, France
    Am J Surg Pathol 31:1887-92. 2007
  4. ncbi [Hematodermic CD4/CD56 neoplasm]
    Tony Petrella
    Centre de Pathologie, 33 rue Nicolas Bornier, BP189, 21005, Dijon Cedex, France
    Ann Pathol 24:241-55; quiz 227. 2004
  5. ncbi Blastic NK-cell lymphomas (agranular CD4+CD56+ hematodermic neoplasms): a review
    Tony Petrella
    Centre de Pathologie, Department of Pathology, Centre Hospitalo-Universitaire, Dijon, France
    Am J Clin Pathol 123:662-75. 2005
  6. ncbi TCL1 and CLA expression in agranular CD4/CD56 hematodermic neoplasms (blastic NK-cell lymphomas) and leukemia cutis
    Tony Petrella
    Centre de Pathologie, Department of Pathology, Centre Hospitalo-Universitaire du Bocage, Dijon, France
    Am J Clin Pathol 122:307-13. 2004
  7. ncbi Alpha-interferon secreting blastic plasmacytoid dendritic cells neoplasm: a case report with histological, molecular genetics and long-term tumor cells culture studies
    Tony Petrella
    Department of Pathology, CHU, Dijon, France
    Am J Dermatopathol 34:626-31. 2012
  8. ncbi Histologic and immunohistologic characterization of skin localization of myeloid disorders: a study of 173 cases
    Claire Bénet
    University Hospital Center, Plateau Biology Technology Gerard Mack, Dijon, France
    Am J Clin Pathol 135:278-90. 2011
  9. ncbi Twenty-five years of epidemiological recording on myeloid malignancies: data from the specialized registry of hematologic malignancies of Cote d'Or (Burgundy, France)
    Marc Maynadie
    Registre des Hémopathies Malignes de Côte d Or, EA 4184, Faculte de Medecine, Dijon Cedex, France
    Haematologica 96:55-61. 2011
  10. ncbi Ultimate results of radiation therapy for T1-T2 mycosis fungoides (including reirradiation)
    Loic Ysebaert
    Radiotherapy Department, Centre G F Leclerc, Dijon, France
    Int J Radiat Oncol Biol Phys 58:1128-34. 2004

Detail Information

Publications17

  1. ncbi 'Agranular CD4+ CD56+ hematodermic neoplasm' (blastic NK-cell lymphoma) originates from a population of CD56+ precursor cells related to plasmacytoid monocytes
    Tony Petrella
    Centre de Pathologie of Dijon and the Department of Pathology, Dijon University Hospital, France
    Am J Surg Pathol 26:852-62. 2002
    ..We therefore propose that oncogenic transformation of NCAM-expressing plasmacytoid monocyte-like cells may lead to "agranular CD4+ CD56+ hematodermic neoplasm."..
  2. ncbi Tumoral aspects of plasmacytoid dendritic cells: what do we know in 2009?
    Tony Petrella
    Centre de Pathologie and Department of Pathology, University Hospital, Dijon, France
    Autoimmunity 43:210-4. 2010
    ..To date, two kinds of tumoral conditions are recognized: the so-called PDCs proliferations in patients with myeloid disorders and the blastic plasmacytoid dendritic cell neoplasm. These two entities are exposed and discussed...
  3. ncbi Indolent CD8-positive lymphoid proliferation of the ear: a distinct primary cutaneous T-cell lymphoma?
    Tony Petrella
    Department of Pathology of Dijon s University Hospital and the Centre de Pathologie of Dijon, 2100 Dijon, France
    Am J Surg Pathol 31:1887-92. 2007
    ..The apparent striking propensity for the ear suggests that they might represent a specific entity. Further cases are needed to confirm this hypothesis. It is important for such indolent lesions to be known to avoid over treatment...
  4. ncbi [Hematodermic CD4/CD56 neoplasm]
    Tony Petrella
    Centre de Pathologie, 33 rue Nicolas Bornier, BP189, 21005, Dijon Cedex, France
    Ann Pathol 24:241-55; quiz 227. 2004
    ..The median time of survival is 14 months irrespective of the treatment given. Conventional chemotherapies used for the treatment of aggressive lymphomas or acute myeloid leukemias are quickly inefficient...
  5. ncbi Blastic NK-cell lymphomas (agranular CD4+CD56+ hematodermic neoplasms): a review
    Tony Petrella
    Centre de Pathologie, Department of Pathology, Centre Hospitalo-Universitaire, Dijon, France
    Am J Clin Pathol 123:662-75. 2005
    ..The major clinical, histopathologic, and phenotypic aspects of the disease and diagnostic criteria and data suggesting a plasmacytoid dendritic cell origin for the tumor cells are provided...
  6. ncbi TCL1 and CLA expression in agranular CD4/CD56 hematodermic neoplasms (blastic NK-cell lymphomas) and leukemia cutis
    Tony Petrella
    Centre de Pathologie, Department of Pathology, Centre Hospitalo-Universitaire du Bocage, Dijon, France
    Am J Clin Pathol 122:307-13. 2004
    ..These results suggest that TCL1 and CLA are good markers for CD4/CD56 HN tumor cells and add support for a plasmacytoid dendritic cell origin. The high skin tropism of CD4/CD56 HN might be related to the skin-homing property of CLA...
  7. ncbi Alpha-interferon secreting blastic plasmacytoid dendritic cells neoplasm: a case report with histological, molecular genetics and long-term tumor cells culture studies
    Tony Petrella
    Department of Pathology, CHU, Dijon, France
    Am J Dermatopathol 34:626-31. 2012
    ..The demonstration of ETV6 gene deletion in this case deserves further investigations as a putative BPDCN marker...
  8. ncbi Histologic and immunohistologic characterization of skin localization of myeloid disorders: a study of 173 cases
    Claire Bénet
    University Hospital Center, Plateau Biology Technology Gerard Mack, Dijon, France
    Am J Clin Pathol 135:278-90. 2011
    ....
  9. ncbi Twenty-five years of epidemiological recording on myeloid malignancies: data from the specialized registry of hematologic malignancies of Cote d'Or (Burgundy, France)
    Marc Maynadie
    Registre des Hémopathies Malignes de Côte d Or, EA 4184, Faculte de Medecine, Dijon Cedex, France
    Haematologica 96:55-61. 2011
    ....
  10. ncbi Ultimate results of radiation therapy for T1-T2 mycosis fungoides (including reirradiation)
    Loic Ysebaert
    Radiotherapy Department, Centre G F Leclerc, Dijon, France
    Int J Radiat Oncol Biol Phys 58:1128-34. 2004
    ..We report on our experience in the treatment of T1 and T2 mycosis fungoides (MF) with total skin electron beam therapy (TSEBT), with respect to relapse-free rate, overall survival rate, and management of recurrence...
  11. ncbi CD56-positive haematological neoplasms of the skin: a multicentre study of the Cutaneous Lymphoma Project Group of the European Organisation for Research and Treatment of Cancer
    Chalid Assaf
    Department of Dermatology, Charite, Berlin, Germany
    J Clin Pathol 60:981-9. 2007
    ..However, prognostic subsets within the CD56+ group have been difficult to identify due to the lack of uniform clinicopathological and immunophenotypical criteria...
  12. ncbi Skin manifestations in CD4+, CD56+ malignancies
    Katell Penven
    Department of Dermatology, Centre Hospitalier Universitaire, Avenue Georges Clemenceau, 14033 Caen Cedex, France
    Eur J Dermatol 13:161-5. 2003
    ..The presence of CD123 antigen in most of the cases is an argument for a plasmacytoid dendritic cell proliferation and it is also a good marker for primary cutaneous lesions...
  13. ncbi Novel markers of normal and neoplastic human plasmacytoid dendritic cells
    Teresa Marafioti
    Leukaemia Research Fund Immunodiagnostics Unit, Nuffield Department of Clinical Laboratory Sciences, John Radcliffe Hospital, Oxford, UK
    Blood 111:3778-92. 2008
    ....
  14. ncbi Subcutaneous panniculitis-like T-cell lymphoma: definition, classification, and prognostic factors: an EORTC Cutaneous Lymphoma Group Study of 83 cases
    Rein Willemze
    Department of Dermatology, Leiden University Medical Center, The Netherlands
    Blood 111:838-45. 2008
    ..SPTL-ABs without associated HPS have an excellent prognosis, and multiagent chemotherapy as first choice of treatment should be questioned...
  15. ncbi [Primary cutaneous lymphomas]
    Janine Wechsler
    Service Anatomie et de Cytologie Pathologiques, ,
    Ann Pathol 27:284-309. 2007
  16. ncbi Bcl-2 protein expression is the strongest independent prognostic factor of survival in primary cutaneous large B-cell lymphomas
    Florent Grange
    Department of Dermatology, Hopital Pasteur, Colmar Cedex, France
    Blood 103:3662-8. 2004
    ..0001). A new prognostic classification of primary cutaneous B-cell lymphoma should be based primarily on bcl-2 protein expression rather than the location of skin lesions...
  17. ncbi Primary cutaneous diffuse large B-cell lymphoma, leg type: clinicopathologic features and prognostic analysis in 60 cases
    Florent Grange
    Department of Dermatology, Hopital Robert Debre, avenue du Général Koenig, Reims 51100, France
    Arch Dermatol 143:1144-50. 2007
    ....